Reference Drug

Phase 3

Innovation Pharmaceuticals Inc. (IPIX)

00%

What is LOA?

Phase 3

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

Upcoming Catalysts

What are catalysts?

Jul '27

IPIXPhase 3$9M

Reference Drug Phase 3 Est. Readout

Reference Drug• Retinal Vein Occlusion With Macular Edema312

Jul 2027~ConfirmedSTALE

CT.gov

00%

Competitive Landscape

0 competitors in Retinal Vein Occlusion With Macular Edema

View Full Landscape

Drug Information

Target Indication

Retinal Vein Occlusion With Macular Edema

Clinical Trial

NCT07708142

Last updated: 7/17/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Source: FDA Orange Book

Drug Science

Mechanism of action & safety profile

Developer

IPIX

Innovation Pharmaceuticals Inc.

Pharmaceutical Preparations•North America•NASDAQ

Related Pipeline

CenerimodPhase 3

Lupus Erythematosus, Systemic

SMZ1Phase 3

Neovascular (Wet) Age-related Macular Degeneration Without Polypoidal Choroidal Vasculopathy

F14Phase 3

Post Operative Pain

Gemcitabine hydrochloride and albumin binding paclitaxelPhase 3

Locally Advanced Pancreatic Cancer

0.05% atropine eye dropsPhase 3

Myopia

View full pipeline

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts